SEARCH RESULTS FOR: 外链资源优化程序方法👉TG@yuantou2048👈谷歌外链发布10万条(181221 results)

Export results
Only the first 10,000 results were returned. Filter these results or refine your query. Some pre-built queries with more than 10,000 results are available for download.
Filters
Sort By
40
Results Per Page
40
Results/Pg
Company Name Brand Name GMDN Term Name GMDN Term Status FDA Product Code Name FDA Product Code Device Packaged As Sterile Sterilization Prior To Use Issuing Agency Device Size Device Size Type Device Class Implantable

Show Filters

ARROW - 10801902194081

Arrow-Trerotola(TM) PTD(R) Kit (Percutaneous Thrombolytic Device)
TELEFLEX INCORPORATED
IPN920365
In Commercial Distribution

  • 20801902194088 ()
  • 10801902194081 ()
PT-65509-HFC

  • Thrombectomy rotational catheter

ARROW - 10801902194043

Arrow-Trerotola(TM) PTD(R)* Rotator Drive Unit
TELEFLEX INCORPORATED
IPN920361
In Commercial Distribution

  • 20801902194040 ()
  • 10801902194043 ()
PT-03000-R

  • Thrombectomy rotational catheter

DRUGS OF ABUSE QC HIGH - B800DAQCHIGHUFUMHC0

DRUGS OF ABUSE QC HIGH
UTAK LABORATORIES, INC.
DA QC HIGH U F UMHC
In Commercial Distribution

  • B800DAQCHIGHUFUMHC5 ()
  • B800DAQCHIGHUFUMHC0 ()

  • Total Volume: 20 Milliliter
DA QC HIGH U F UMHC

  • Multiple-type clinical chemistry analyte profile IVD, control

DRUGS OF ABUSE POSITIVE - B800DAPOSV2WBFKBI0

DRUGS OF ABUSE POSITIVE
UTAK LABORATORIES, INC.
DA POS V2 WB F KBI
In Commercial Distribution

  • B800DAPOSV2WBFKBI5 ()
  • B800DAPOSV2WBFKBI0 ()

  • Total Volume: 3 Milliliter
DA POS V2 WB F KBI

  • Multiple drugs of abuse IVD, control

DRUGS OF ABUSE POSITIVE - B800DAPOSBMFMMB0

DRUGS OF ABUSE POSITIVE
UTAK LABORATORIES, INC.
DA POS BM F MMB
In Commercial Distribution

  • B800DAPOSBMFMMB5 ()
  • B800DAPOSBMFMMB0 ()

  • Total Volume: 5 Milliliter
DA POS BM F MMB

  • Multiple drugs of abuse IVD, control

DRUGS OF ABUSE LEVEL 2 - B800DAOF2FPM0

DRUGS OF ABUSE LEVEL 2
UTAK LABORATORIES, INC.
DA OF 2 F PM
In Commercial Distribution

  • B800DAOF2FPM5 ()
  • B800DAOF2FPM0 ()

  • Total Volume: 3 Milliliter
DA OF 2 F PM

  • Multiple drugs of abuse IVD, control

DRUGS OF ABUSE LEVEL 2 - B800DAOF2FADX0

DRUGS OF ABUSE LEVEL 2
UTAK LABORATORIES, INC.
DA OF 2 F ADX
In Commercial Distribution

  • B800DAOF2FADX5 ()
  • B800DAOF2FADX0 ()

  • Total Volume: 3 Milliliter
DA OF 2 F ADX

  • Multiple drugs of abuse IVD, control

DRUGS OF ABUSE LEVEL 1 - B800DAOF1FPM0

DRUGS OF ABUSE LEVEL 1
UTAK LABORATORIES, INC.
DA OF 1 F PM
In Commercial Distribution

  • B800DAOF1FPM5 ()
  • B800DAOF1FPM0 ()

  • Total Volume: 3 Milliliter
DA OF 1 F PM

  • Multiple drugs of abuse IVD, control

DRUGS OF ABUSE LEVEL 1 - B800DAOF1FADX0

DRUGS OF ABUSE LEVEL 1
UTAK LABORATORIES, INC.
DA OF 1 F ADX
In Commercial Distribution

  • B800DAOF1FADX5 ()
  • B800DAOF1FADX0 ()

  • Total Volume: 3 Milliliter
DA OF 1 F ADX

  • Multiple drugs of abuse IVD, control

DRUGS OF ABUSE NEGATIVE - B800DANEGBMFMMB0

DRUGS OF ABUSE NEGATIVE
UTAK LABORATORIES, INC.
DA NEG BM F MMB
In Commercial Distribution

  • B800DANEGBMFMMB5 ()
  • B800DANEGBMFMMB0 ()

  • Total Volume: 5 Milliliter
DA NEG BM F MMB

  • Multiple drugs of abuse IVD, control

DRUGS OF ABUSE - B800DAMFPLV20

DRUGS OF ABUSE
UTAK LABORATORIES, INC.
DA M F PL V2
In Commercial Distribution

  • B800DAMFPLV25 ()
  • B800DAMFPLV20 ()

  • Total Volume: 5 Milliliter
DA M F PL V2

  • Multiple-type clinical chemistry analyte profile IVD, control

DRUGS OF ABUSE - B800DAMFHD0

DRUGS OF ABUSE
UTAK LABORATORIES, INC.
DA M F HD
In Commercial Distribution

  • B800DAMFHD5 ()
  • B800DAMFHD0 ()

  • Total Volume: 5 Milliliter
DA M F HD

  • Multiple drugs of abuse IVD, control

DRUGS OF ABUSE LOW - B800DALOWV2WBFBTL0

DRUGS OF ABUSE LOW
UTAK LABORATORIES, INC.
DA LOW V2 WB F BTL
In Commercial Distribution

  • B800DALOWV2WBFBTL5 ()
  • B800DALOWV2WBFBTL0 ()

  • Total Volume: 1 Milliliter
DA LOW V2 WB F BTL

  • Multiple drugs of abuse IVD, control

DRUGS OF ABUSE HIGH - B800DAHIGHV2WBFBTL0

DRUGS OF ABUSE HIGH
UTAK LABORATORIES, INC.
DA HIGH V2 WB F BTL
In Commercial Distribution

  • B800DAHIGHV2WBFBTL5 ()
  • B800DAHIGHV2WBFBTL0 ()

  • Total Volume: 1 Milliliter
DA HIGH V2 WB F BTL

  • Multiple drugs of abuse IVD, control

DRUGS OF ABUSE CUTOFF - B800DACUTV2SFPL0

DRUGS OF ABUSE CUTOFF
UTAK LABORATORIES, INC.
DA CUT V2 S F PL
In Commercial Distribution

  • B800DACUTV2SFPL5 ()
  • B800DACUTV2SFPL0 ()

  • Total Volume: 5 Milliliter
DA CUT V2 S F PL

  • Multiple-type clinical chemistry analyte profile IVD, control

DRUGS OF ABUSE PLUS LEVEL 4 - B800DA4WBV3IMMUN0

DRUGS OF ABUSE PLUS LEVEL 4
UTAK LABORATORIES, INC.
DA+4 WB V3 IMMUN
In Commercial Distribution

  • B800DA4WBV3IMMUN5 ()
  • B800DA4WBV3IMMUN0 ()

  • Total Volume: 1 Milliliter
DA+4 WB V3 IMMUN

  • Multiple-type clinical chemistry analyte profile IVD, control

DRUGS OF ABUSE PLUS LEVEL 4 - B800DA4WBV2IMMUN0

DRUGS OF ABUSE PLUS LEVEL 4
UTAK LABORATORIES, INC.
DA+4 WB V2 IMMUN
In Commercial Distribution

  • B800DA4WBV2IMMUN5 ()
  • B800DA4WBV2IMMUN0 ()

  • Total Volume: 1 Milliliter
DA+4 WB V2 IMMUN

  • Multiple therapeutic drugs/drugs of abuse IVD, control

DRUGS OF ABUSE PLUS LEVEL 4 - B800DA4WBIMMUN0

DRUGS OF ABUSE PLUS LEVEL 4
UTAK LABORATORIES, INC.
DA+ 1 WB IMMUN
In Commercial Distribution

  • B800DA4WBIMMUN5 ()
  • B800DA4WBIMMUN0 ()

  • Total Volume: 1 Milliliter
DA+ 1 WB IMMUN

  • Multiple drugs of abuse IVD, control

DRUGS OF ABUSE LEVEL 4 - B800DA4WBFRIDH0

DRUGS OF ABUSE LEVEL 4
UTAK LABORATORIES, INC.
DA 4 WB F RIDH
In Commercial Distribution

  • B800DA4WBFRIDH5 ()
  • B800DA4WBFRIDH0 ()

  • Total Volume: 1 Milliliter
DA 4 WB F RIDH

  • Multiple therapeutic drugs/drugs of abuse IVD, control

DRUGS OF ABUSE PLUS LEVEL 3 - B800DA3WBV2IMMUN0

DRUGS OF ABUSE PLUS LEVEL 3
UTAK LABORATORIES, INC.
DA+3 WB V2 IMMUN
In Commercial Distribution

  • B800DA3WBV2IMMUN5 ()
  • B800DA3WBV2IMMUN0 ()

  • Total Volume: 1 Milliliter
DA+3 WB V2 IMMUN

  • Multiple therapeutic drugs/drugs of abuse IVD, control

DRUGS OF ABUSE PLUS LEVEL 3 - B800DA3WBIMMUN0

DRUGS OF ABUSE PLUS LEVEL 3
UTAK LABORATORIES, INC.
DA+ 3 WB IMMUN
In Commercial Distribution

  • B800DA3WBIMMUN0 ()

  • Total Volume: 1 Milliliter
DA+ 3 WB IMMUN

  • Multiple drugs of abuse IVD, control

DRUGS OF ABUSE LEVEL 3 - B800DA3WBFRIDH0

DRUGS OF ABUSE LEVEL 3
UTAK LABORATORIES, INC.
DA 3 WB F RIDH
In Commercial Distribution

  • B800DA3WBFRIDH5 ()
  • B800DA3WBFRIDH0 ()

  • Total Volume: 1 Milliliter
DA 3 WB F RIDH

  • Multiple therapeutic drugs/drugs of abuse IVD, control

DRUGS OF ABUSE PLUS LEVEL 2 - B800DA2WBV2IMMUN0

DRUGS OF ABUSE PLUS LEVEL 2
UTAK LABORATORIES, INC.
DA+2 WB V2 IMMUN
In Commercial Distribution

  • B800DA2WBV2IMMUN5 ()
  • B800DA2WBV2IMMUN0 ()

  • Total Volume: 1 Milliliter
DA+2 WB V2 IMMUN

  • Multiple therapeutic drugs/drugs of abuse IVD, control

DRUGS OF ABUSE PLUS LEVEL 2 - B800DA2WBIMMUN0

DRUGS OF ABUSE PLUS LEVEL 2
UTAK LABORATORIES, INC.
DA+ 2 WB IMMUN
In Commercial Distribution

  • B800DA2WBIMMUN0 ()

  • Total Volume: 1 Milliliter
DA+ 2 WB IMMUN

  • Multiple drugs of abuse IVD, control

DRUGS OF ABUSE LEVEL 2 - B800DA2WBFRIDH0

DRUGS OF ABUSE LEVEL 2
UTAK LABORATORIES, INC.
DA 2 WB F RIDH
In Commercial Distribution

  • B800DA2WBFRIDH5 ()
  • B800DA2WBFRIDH0 ()

  • Total Volume: 1 Milliliter
DA 2 WB F RIDH

  • Multiple therapeutic drugs/drugs of abuse IVD, control

DRUGS OF ABUSE LEVEL 2 - B800DA2V2FWBTDHS0

DRUGS OF ABUSE LEVEL 2
UTAK LABORATORIES, INC.
DA 2 V2 F WB TDHS
In Commercial Distribution

  • B800DA2V2FWBTDHS5 ()
  • B800DA2V2FWBTDHS0 ()

  • Total Volume: 5 Milliliter
DA 2 V2 F WB TDHS

  • Multiple drugs of abuse IVD, control

DRUGS OF ABUSE LEVEL 2 - B800DA2SFLLS0

DRUGS OF ABUSE LEVEL 2
UTAK LABORATORIES, INC.
DA 2 S F LLS
In Commercial Distribution

  • B800DA2SFLLS0 ()

  • Total Volume: 2 Milliliter
DA 2 S F LLS

  • Multiple drugs of abuse IVD, control

DA2FWBAHT - B800DA2FWBAHT0

DA2FWBAHT
UTAK LABORATORIES, INC.
DA 2 F WB AHT
In Commercial Distribution

  • B800DA2FWBAHT5 ()
  • B800DA2FWBAHT0 ()

  • Total Volume: 5 Milliliter
DA 2 F WB AHT

  • Multiple-type clinical chemistry analyte profile IVD, control

DRUGS OF ABUSE 1 - B800DA1WBVTS0

DRUGS OF ABUSE 1
UTAK LABORATORIES, INC.
DA 1 WB VTS
In Commercial Distribution

  • B800DA1WBVTS5 ()
  • B800DA1WBVTS0 ()

  • Total Volume: 25 Milliliter
DA 1 WB VTS

  • Multiple-type clinical chemistry analyte profile IVD, control

DRUGS OF ABUSE PLUS LEVEL 1 - B800DA1WBV2IMMUN0

DRUGS OF ABUSE PLUS LEVEL 1
UTAK LABORATORIES, INC.
DA+1 WB V2 IMMUN
In Commercial Distribution

  • B800DA1WBV2IMMUN5 ()
  • B800DA1WBV2IMMUN0 ()

  • Total Volume: 1 Milliliter
DA+1 WB V2 IMMUN

  • Multiple therapeutic drugs/drugs of abuse IVD, control

DRUGS OF ABUSE PLUS LEVEL 1 - B800DA1WBIMMUN0

DRUGS OF ABUSE PLUS LEVEL 1
UTAK LABORATORIES, INC.
DA+ 1 WB IMMUN
In Commercial Distribution

  • B800DA1WBIMMUN5 ()
  • B800DA1WBIMMUN0 ()

  • Total Volume: 1 Milliliter
DA+ 1 WB IMMUN

  • Multiple drugs of abuse IVD, control

DRUGS OF ABUSE LEVEL 1 - B800DA1WBFRIDH0

DRUGS OF ABUSE LEVEL 1
UTAK LABORATORIES, INC.
DA 1 WB F RIDH
In Commercial Distribution

  • B800DA1WBFRIDH5 ()
  • B800DA1WBFRIDH0 ()

  • Total Volume: 1 Milliliter
DA 1 WB F RIDH

  • Multiple therapeutic drugs/drugs of abuse IVD, control

DRUGS OF ABUSE LEVEL 1 - B800DA1SFLLS0

DRUGS OF ABUSE LEVEL 1
UTAK LABORATORIES, INC.
DA 1 S F LLS
In Commercial Distribution

  • B800DA1SFLLS5 ()
  • B800DA1SFLLS0 ()

  • Total Volume: 2 Milliliter
DA 1 S F LLS

  • Multiple drugs of abuse IVD, control

DA SET 1 POSITIVE - B800DA1POSSNC0

DA SET 1 POSITIVE
UTAK LABORATORIES, INC.
DA 1 POS S NC
In Commercial Distribution

  • B800DA1POSSNC5 ()
  • B800DA1POSSNC0 ()

  • Total Volume: 2 Milliliter
DA 1 POS S NC

  • Multiple therapeutic drugs/drugs of abuse IVD, control

DA SET 1 CUTOFF - B800DA1CUTWBNC0

DA SET 1 CUTOFF
UTAK LABORATORIES, INC.
DA 1 CUT WB NC
In Commercial Distribution

  • B800DA1CUTWBNC5 ()
  • B800DA1CUTWBNC0 ()

  • Total Volume: 2 Milliliter
DA 1 CUT WB NC

  • Multiple-type clinical chemistry analyte profile IVD, control

DA SET 1 CUTOFF - B800DA1CUTSNC0

DA SET 1 CUTOFF
UTAK LABORATORIES, INC.
DA 1 CUT S NC
In Commercial Distribution

  • B800DA1CUTSNC5 ()
  • B800DA1CUTSNC0 ()

  • Total Volume: 2 Milliliter
DA 1 CUT S NC

  • Multiple therapeutic drugs/drugs of abuse IVD, control

CREATININE LEVEL 1 - B800CREAT1WBFLCG0

CREATININE LEVEL 1
UTAK LABORATORIES, INC.
CREAT 1 WB F LCG
In Commercial Distribution

  • B800CREAT1WBFLCG5 ()
  • B800CREAT1WBFLCG0 ()

  • Total Volume: 50 Milliliter
CREAT 1 WB F LCG

  • Multiple-type clinical chemistry analyte profile IVD, control

CLOZAPINE PLUS - B800CLOZSAQ0

CLOZAPINE PLUS
UTAK LABORATORIES, INC.
CLOZ+ S AQ
In Commercial Distribution

  • B800CLOZSAQ5 ()
  • B800CLOZSAQ0 ()

  • Total Volume: 5 Milliliter
CLOZ+ S AQ

  • Multiple-type clinical chemistry analyte profile IVD, control

CLOFARABINE PLUS LEVEL 3 - B800CLOF3DPFMSKCC0

CLOFARABINE PLUS LEVEL 3
UTAK LABORATORIES, INC.
CLOF+ 3 DP F MSKCC
In Commercial Distribution

  • B800CLOF3DPFMSKCC5 ()
  • B800CLOF3DPFMSKCC0 ()

  • Total Volume: 0.5 Milliliter
CLOF+ 3 DP F MSKCC

  • Multiple-type clinical chemistry analyte profile IVD, control

CLOFARABINE PLUS LEVEL 2 - B800CLOF2DPFMSKCC0

CLOFARABINE PLUS LEVEL 2
UTAK LABORATORIES, INC.
CLOF+ 2 DP F MSKCC
In Commercial Distribution

  • B800CLOF2DPFMSKCC5 ()
  • B800CLOF2DPFMSKCC0 ()

  • Total Volume: 0.5 Milliliter
CLOF+ 2 DP F MSKCC

  • Multiple-type clinical chemistry analyte profile IVD, control
< 1 ... 223 224 225 226 227 ... 250 >